Literature DB >> 18672639

Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.

Sirisanpang Yodavudh1, Siriwan Tangjitgamol, Supalarp Puangsa-art.   

Abstract

BACKGROUND: Angiogenesis has been found to be a reliable prognostic indicator for several types of malignancies. In colorectal cancer, however there has been controversy as to whether there is a correlation between this feature and the tumors' behavior.
OBJECTIVE: Determine the correlation between microvessel density (MVD) and mast cell density (MCD) in order to evaluate these factors in terms of their prognostic relevance for primary colorectal carcinoma in Thai patients. MATERIAL AND
METHOD: One hundred and thirty colorectal carcinoma patients diagnosed between January 2002 and December 2004 were identified. Eleven patients were excluded from the present study due to recurrence of colorectal carcinoma in eight cases whereas pathologic blocks were not found in three cases. One hundred and nineteen patients met all inclusion criteria and were included in the present study. Representative paraffin sections obtained by the tissue micro-array technique (9 x 5 arrays per slide) from areas of highest vascular density (hot spots) were prepared. Sections were immuno-stained by monoclonal anti CD 31 for microvessel and antibody mast cell tryptase for mast cell detections, respectively. Three readings at different periods of time under a microscopic examination of high power magnification were examined by a pathologist who was blinded to clinical data. The highest microvessel and mast cell counts were recorded as MVD and MCD. Patients were then divided into groups of high and low MVD and high and low MCD by median values (20.5 and 14.5, respectively). Overall survival of the patients in each group was estimated by the Kaplan-Meier Method while a multivariate Cox regression backward stepwise analysis was employed to find out independent prognostic factors.
RESULTS: Significant positive correlation was found to exist between MVD and MCD in the hot spots (R = 0.697, p < 0.0001). Regarding their prognostic role, patients with tumors of low MVD (hypovascular) and low MCD (low mast cell counts) had significantly longer survival rates than those with hypervascular and high mast cell counts (p < 0.0001). The Multivariate Cox hazard showed that MVD and distance metastasis of cancer were independent poor prognostic factors to survival (p = 0.036 and p = 0.024, respectively). The patients with high MVD (hypervascular) tumors and with presence of distant metastasis had 1.9 and 2.5 times higher death rates than the corresponding hypovascular and non-metastatic groups, respectively during the period from January 2002 to September 2007.
CONCLUSION: Assessment of microvessel density in the invasive front of primary colorectal carcinoma could serve as useful prognosis tool of primary colorectal carcinoma in Thai patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672639

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  21 in total

1.  Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.

Authors:  Matthew J Strouch; Eric C Cheon; Mohammad R Salabat; Seth B Krantz; Elias Gounaris; Laleh G Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G Munshi; Khashayarsha Khazaie; David J Bentrem
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention.

Authors:  Michele Ammendola; Valeria Zuccalà; Rosa Patruno; Emilio Russo; Maria Luposella; Andrea Amorosi; Giuseppina Vescio; Giuseppe Sammarco; Severino Montemurro; Giovambattista De Sarro; Rosario Sacco; Girolamo Ranieri
Journal:  Updates Surg       Date:  2012-11-02

3.  A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Authors:  Eun-A Ko; Kenton M Sanders; Tong Zhou
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

Review 4.  The colorectal cancer immune microenvironment and approach to immunotherapies.

Authors:  Minoru Koi; John M Carethers
Journal:  Future Oncol       Date:  2017-08-22       Impact factor: 3.404

5.  Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Authors:  Ashraf Fakhrjou; Seid Mahdi Niroumand-Oscoei; Mohamad Hosein Somi; Morteza Ghojazadeh; Shahnaz Naghashi; Shabnam Samankan
Journal:  J Gastrointest Cancer       Date:  2014-03

6.  PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer.

Authors:  Mohammad W Khan; Ali Keshavarzian; Elias Gounaris; Joshua E Melson; Eric C Cheon; Nichole R Blatner; Zongmin E Chen; Fu-Nien Tsai; Goo Lee; Hyunji Ryu; Terrence A Barrett; David J Bentrem; Philipp Beckhove; Khashayarsha Khazaie
Journal:  Clin Cancer Res       Date:  2013-03-13       Impact factor: 12.531

7.  Mast Cells in Adjacent Normal Colon Mucosa rather than Those in Invasive Margin are Related to Progression of Colon Cancer.

Authors:  Qing Xia; Ya Ding; Xiao-Jun Wu; Rui-Qing Peng; Qiang Zhou; Jing Zeng; Jing-Hui Hou; Xing Zhang; Yi-Xin Zeng; Xiao-Shi Zhang; Ying-Bo Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

Review 8.  Possible biological and translational significance of mast cells density in colorectal cancer.

Authors:  Ilaria Marech; Michele Ammendola; Claudia Gadaleta; Nicola Zizzo; Caroline Oakley; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

10.  Mast cells impair the development of protective anti-tumor immunity.

Authors:  Anna Wasiuk; Dyana K Dalton; William L Schpero; Radu V Stan; Jose R Conejo-Garcia; Randolph J Noelle
Journal:  Cancer Immunol Immunother       Date:  2012-06-10       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.